bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

15,108 Articles (11,672 medRxiv, 3,436 bioRxiv)

Most recent first Previous |  Page 6: Articles 51-60  | Next

Modeling COVID-19 in Iran using Particle Swarm Optimization algorithm
Sahafizadeh, E., Khajeian, M.
10.1101/2021.04.10.21255244 — Posted: 2021-04-15
REACT-1 round 10 report: Level prevalence of SARS-CoV-2 swab-positivity in England during third national lockdown in March 2021
Riley, S., Eales, O., Haw, D., Walters, C. E., Wang, H., Ainslie, K. E. C., Atchinson, C., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2021.04.08.21255100 — Posted: 2021-04-15
Sensitivity of rapid antigen testing and RT-PCR performed on nasopharyngeal swabs versus saliva samples in COVID-19 hospitalized patients: results of a prospective comparative trial (RESTART).
Kritikos, A., Caruana, G., Brouillet, R., Miroz, J.-P., Abed-Maillard, S., Stieger, G., Opota, O., Croxatto, A., Vollenweider, P., Bart, P.-A., Chiche, J.-D., Greub, G.
10.1101/2021.04.09.21255105 — Posted: 2021-04-15
IL-1α Mediates Tissue Specific Inflammation and Severe Respiratory Failure In Covid-19: Clinical And Experimental Evidence
Renieris, G., Karakike, E., Xu, Z., Gkavogianni, T., Droggiti, D.- E., Schubert, K., Kafousopoulos, D., Hermann, M., Netea, M. G., Eugen-Olsen, J., Simard, J., Giamarellos-Bourboulis, E. J.
10.1101/2021.04.09.21255190 — Posted: 2021-04-15
Continuing COVID-19 Vaccination of Front-Line Workers in British Columbia with the AstraZeneca Vaccine: Benefits in the Face of Increased Risk for Prothrombotic Thrombocytopenia
Adibi, A., Mozafarihashjin, M., Sadatsafavi, M.
10.1101/2021.04.11.21255138 — Posted: 2021-04-15
Spread of the SARS-CoV-2 UK-variant in the South East of France: impact on COVID-19 patients age, comorbidity profiles and clinical presentation, week 50 2020 to week 8 2021
Courjon, J.-V., Contenti, J., Demonchy, E., Levraut, J., Barbry, P., Rios, G., Dellamonica, J., Chirio, D., Bonnefoy, C., Giordanengo, V., Carles, M.
10.1101/2021.04.12.21253817 — Posted: 2021-04-15
Predicting severe COVID-19 outcomes for triage and resource allocation
Morada, A. O., Scheidel, C., Brown, J. L., Albright, J., Kolade, V., Cagir, B.
10.1101/2021.04.12.21255201 — Posted: 2021-04-15
The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD
Greaney, A. J., Loes, A. N., Gentles, L. E., Crawford, K. H., Starr, T. N., Malone, K. D., Chu, H. Y., Bloom, J. D.
10.1101/2021.04.14.439844 — Posted: 2021-04-14
Pattern Detection in Multiple Genome Sequences with Applications: The Case of All SARS-CoV-2 Complete Variants
Xylogiannopoulos, K.
10.1101/2021.04.14.439840 — Posted: 2021-04-14
Community level misconception about COVID-19 and its associated factors: Evidence from a cross-sectional study in Bangladesh
Bakebillah, M., Billah, M. A., Wubishet, B. L., Khan, M. N.
10.1101/2021.04.12.21254829 — Posted: 2021-04-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).